Cengild Medical Berhad
Cengild Medical Berhad, an investment holding company, operates a medical center in Malaysia. The company offers various care and treatment consultant services for gastrointestinal and liver diseases, morbid obesity, and oncology and urological conditions; general cardiology and gynecology assessment; gastroenterology and hepatology; anesthesiology, general surgery, internal medicine, and radiolo… Read more
Cengild Medical Berhad (0243) - Total Liabilities
Latest total liabilities as of December 2025: RM101.09 Million MYR
Based on the latest financial reports, Cengild Medical Berhad (0243) has total liabilities worth RM101.09 Million MYR as of December 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Cengild Medical Berhad - Total Liabilities Trend (2020–2025)
This chart illustrates how Cengild Medical Berhad's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Cengild Medical Berhad Competitors by Total Liabilities
The table below lists competitors of Cengild Medical Berhad ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Decent Holding Inc Ordinary Shares
NASDAQ:DXST
|
USA | $9.45 Million |
|
Openknowl Co.,Ltd.
KQ:440320
|
Korea | ₩41.04 Billion |
|
Vipul Limited
NSE:VIPULLTD
|
India | ₹7.78 Billion |
|
Mundoro Capital Inc
OTCQB:MUNMF
|
USA | $5.17 Million |
|
DPSC Limited
NSE:DPSCLTD
|
India | ₹9.35 Billion |
|
Spencer's Retail Limited
NSE:SPENCERS
|
India | ₹20.73 Billion |
|
SOC D'EXP VIOR
F:VL5
|
Germany | €11.32 Million |
|
Abliva AB (publ)
PINK:NEVPF
|
USA | $11.86 Million |
Liability Composition Analysis (2020–2025)
This chart breaks down Cengild Medical Berhad's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.90 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.86 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.46 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Cengild Medical Berhad's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Cengild Medical Berhad (2020–2025)
The table below shows the annual total liabilities of Cengild Medical Berhad from 2020 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | RM66.03 Million | +212.27% |
| 2024-06-30 | RM21.15 Million | -17.46% |
| 2023-06-30 | RM25.62 Million | -3.66% |
| 2022-06-30 | RM26.59 Million | -17.41% |
| 2021-06-30 | RM32.20 Million | -13.68% |
| 2020-06-30 | RM37.30 Million | -- |